Laurent yon, Johann Guillemot, Maite Montero-Hadjadje, Luca Grumolato, Jérôme Leprince, et al.. Identification of the Secretogranin II-Derived Peptide EM66 in Pheochromocytomas as a Potential Marker for Discriminating Benign Versus Malignant Tumors.
Journal of Clinical Endocrinology and Metabolism, Endocrine Society, 2003, 88 (6), pp.2579-2585.
⟨10.1210/jc.2002-021748⟩.
⟨hal-01706414⟩